A Case of EGFR Mutant Lung Adenocarcinoma That Acquired Resistance to EGFR-tyrosine Kinase Inhibitors With MET Amplification and Epithelial-To-Mesenchymal Transition
OncoTargets and Therapy - New Zealand
doi 10.2147/ott.s78911
Full Text
Open PDFAbstract
Available in full text
Date
April 1, 2015
Authors
Publisher
Informa UK Limited